External controls for rare disease drug development: Lessons for emerging and advanced therapeutic modalities
Molecular Therapy Advances · 2026-06 · 34 (2) · 201754
DOI: 10.1016/j.omta.2026.201754 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Therapy Advances, 2026-06. Verfasst von Samuel H Hughes und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Experimental Neurotherapeutics, St. Jude Children's Research Hospital, Memphis, TN, USA. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Spinal Muscular Atrophy Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Center for Experimental Neurotherapeutics, St. Jude Children's Research Hospital, Memphis, TN, USA.
- American Society of Gene and Cell Therapy, Waukesha, WI, USA.
- Head of Gene Therapy Research, Ultragenyx Pharmaceutical, Somerville, MA, USA.
- Global Clinical Development, Ultragenyx Pharmaceutical, Novato, CA, USA.
- Patient Engagement Research and Development, Bayer AG, New York, NY, USA.
- Hemophilia & Thrombophilia Center, Rush University Medical Center, Chicago, IL, USA.
Förderung
- Spinal Muscular Atrophy Foundation
Zitieren
APA
Hughes, S. H., Beretich, L. A., Fuller, M., Goodspeed, K., Penn, M., Valentino, L. A., & McCombs, C. (2026). External controls for rare disease drug development: Lessons for emerging and advanced therapeutic modalities. Molecular Therapy Advances, 34(2), 201754. https://doi.org/10.1016/j.omta.2026.201754
Vancouver
Hughes SH, Beretich LA, Fuller M, Goodspeed K, Penn M, Valentino LA, et al. External controls for rare disease drug development: Lessons for emerging and advanced therapeutic modalities. Molecular Therapy Advances. 2026;34(2):201754. doi:10.1016/j.omta.2026.201754
BibTeX
@article{Hughes2026,
author = {Hughes, Samuel H and Beretich, Lauren A and Fuller, Matthew and Goodspeed, Kimberly and Penn, Melissa and Valentino, Leonard A and McCombs, Caitlin},
title = {External controls for rare disease drug development: Lessons for emerging and advanced therapeutic modalities},
journal = {Molecular Therapy Advances},
year = {2026},
volume = {34},
number = {2},
pages = {201754},
doi = {10.1016/j.omta.2026.201754}
}
EUVIMED